Please wait while the formulary information is being retrieved.
Drug overview for COUGH SYRUP (guaifenesin):
Generic name: GUAIFENESIN (gwye-FEN-e-sin)
Drug class: Expectorants
Therapeutic class: Respiratory Therapy Agents
Guaifenesin is an expectorant.
No enhanced Uses information available for this drug.
Generic name: GUAIFENESIN (gwye-FEN-e-sin)
Drug class: Expectorants
Therapeutic class: Respiratory Therapy Agents
Guaifenesin is an expectorant.
No enhanced Uses information available for this drug.
DRUG IMAGES
- No Image Available
The following indications for COUGH SYRUP (guaifenesin) have been approved by the FDA:
Indications:
Cold symptoms
Cough
Professional Synonyms:
None.
Indications:
Cold symptoms
Cough
Professional Synonyms:
None.
The following dosing information is available for COUGH SYRUP (guaifenesin):
No enhanced Dosing information available for this drug.
Guaifenesin is administered orally. Mucinex(R) 600-mg extended-release tablets should not be broken, crushed, or chewed and should not be used in children younger than 12 years of age; the tablets should be kept out of reach of young children to avoid accidental swallowing and choking.
DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
---|---|---|
COUGH SYRUP 100 MG/5 ML | Maintenance | Adults take 10 milliliters (200 mg) by oral route every 4 hours as needed |
DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
---|---|---|
GUAIFENESIN 200 MG/10 ML CUP | Maintenance | Adults take 10 milliliters (200 mg) by oral route every 4 hours as needed |
GUAIFENESIN 100MG/5ML SOLN CUP | Maintenance | Adults take 10 milliliters (200 mg) by oral route every 4 hours as needed |
GUAIFENESIN 300 MG/15 ML CUP | Maintenance | Adults take 10 milliliters (200 mg) by oral route every 4 hours as needed |
GUAIFENESIN 100 MG/5 ML SOLN | Maintenance | Adults take 10 milliliters (200 mg) by oral route every 4 hours as needed |
GUAIFENESIN 200 MG/10 ML LIQ | Maintenance | Adults take 10 milliliters (200 mg) by oral route every 4 hours as needed |
The following drug interaction information is available for COUGH SYRUP (guaifenesin):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for COUGH SYRUP (guaifenesin):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 0 contraindications.
There are 0 severe contraindications.
There are 1 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
Moderate List |
---|
No disease contraindications |
The following adverse reaction information is available for COUGH SYRUP (guaifenesin):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 0 severe adverse reactions.
There are 3 less severe adverse reactions.
More Frequent | Less Frequent |
---|---|
None. | None. |
Rare/Very Rare |
---|
Gastrointestinal irritation Nausea Vomiting |
The following precautions are available for COUGH SYRUP (guaifenesin):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
None |
Severe Precaution
None |
Management or Monitoring Precaution
None |
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
Precaution Exists
Precaution exists. (No data or inconclusive human data.) Use of this drug by breast feeding mothers should be evaluated carefully.
Precaution Exists
Precaution exists. (No data or inconclusive human data.) Use of this drug by breast feeding mothers should be evaluated carefully.
Drug Name | Excretion Potential | Effect on Infant | Notes |
---|---|---|---|
Guaifenesin | Unknown. It is unknown whether the drug is excreted in human breast milk. | It is not known whether this drug has an adverse effect on the nursing infant. (No data or inconclusive human data) | Insuff data avail; avoid products with high alcohol content |
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for COUGH SYRUP (guaifenesin):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for COUGH SYRUP (guaifenesin)'s list of indications:
Cold symptoms | |
J00 | Acute nasopharyngitis [common cold] |
Cough | |
R05 | Cough |
R05.1 | Acute cough |
R05.2 | Subacute cough |
R05.3 | Chronic cough |
R05.9 | Cough, unspecified |
Formulary Reference Tool